ArticleBritish journal of cancer2026
Notch signaling governs colorectal cancer metastasis via transcriptional control of TGF-β effectors SMAD2/SMAD3.
Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 10-Hydroxy-2-decenoic Acid Suppresses Colorectal Cancer Progression by Inhibiting Wnt/β-Catenin Signaling and Promoting Apoptosis.Foods (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe molecular interplay between Notch and TGF-β signaling in colorectal cancer (CRC) metastasis remains poorly understood.
methodsGenetic ablation of RBP-J, the central transcriptional mediator of Notch signaling, was performed in CRC cells. In vitro functional assays assessed migration, invasion, and transendothelial migration. Metastatic colonization was evaluated in vivo using orthotopic, intrasplenic, and intravenous murine models. Whole-transcriptome analysis, chromatin immunoprecipitation sequencing (ChIP-seq), and luciferase reporter assays were used to analyze RBP-J-mediated transcriptional regulation of SMAD2/SMAD3. Rescue experiments reconstituted SMAD2/SMAD3 in RBP-J knockout (KO) cells to verify functional necessity.
resultsRBP-J knockout profoundly impaired CRC cell migration, invasion, and transendothelial migration in vitro, and suppressed metastatic colonization across multiple in vivo models. Transcriptomic and ChIP-seq analyses revealed RBP-J directly binds to SMAD2 and SMAD3 promoters and activates their transcription. Reconstitution of SMAD2/SMAD3 restored the migratory and metastatic capacities of RBP-J KO cells. Mechanistically, Notch signaling primes TGF-β responsiveness by maintaining SMAD2/SMAD3 expression and phosphorylation, establishing a feedforward loop essential for metastasis.
conclusionNotch signaling orchestrates TGF-β-driven metastasis through direct transcriptional control of SMAD2/SMAD3, defining a hierarchical regulatory axis. This offers novel therapeutic targets for metastatic CRC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.